RAC 2.92% $1.94 race oncology ltd

Industry news, page-1689

  1. 90 Posts.
    lightbulb Created with Sketch. 26
    To me it looks like there is already more and more emphasis being put on m6a. The new strategy in November and the investor update in May both speak more about FTO being a part of the "m6a opportunity" (FTO appears only as a slide in the appendix of the investor update).
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.